Search
for
Sort by
Research 31–60 of 66
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Steroid Hormones
- Androgen Receptor Ligands: Agonists and Antagonists
- The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients
- Bioavailability File: Bicalutamide
- The Serum Evaluation of Sex Hormones Including DHEAs, DHT, Testosterone in Oral Lichen Planus Patients
- Contaminants of emerging concern in the fetal environment
- Chemically Induced Hair Loss/Alopecia
- Steroid Hormones of Reproduction and Sexual Development
- Dermatologic care of the transgender patient - eScholarship
- Index
- Fluridil, a Rationally Designed Topical Agent for Androgenetic Alopecia
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Alopecia androgenética e seus tratamentos alternativos: uma revisão de literatura
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
- Bicalutamide: A review
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Table_2.docx
- Table_1.docx
- WARFARIN
- Progestogens with Antiandrogenic Properties
- Androgen sensitivity gateway to COVID‐19 disease severity
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- A systematic review of antiandrogens and feminization in transgender women
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer